Hanmi Pharmaceutical said Thursday that its foreign partners are facilitating the global commercialization of the company’s anticancer drug candidates, such as HM43239, belvarafenib, and poziotinib.Aptose Bioscience, Roche and its subsidiary Genentech, and Spectrum Pharmaceuticals are speeding up th
Civic groups accused Pfizer of abusing power against governments over Covid-19 vaccine negotiations around the world.The Korean government should disclose the vaccine purchase agreement signed with Pfizer, and the company should stop monopolistic sales of the Covid-19 vaccine and waive vaccine paten
Genexine said that the Ministry of Food and Drug Safety has approved its investigational new drug (IND) application for conducting a phase 2 clinical trial using its GX-I7 and Roche's Avastin to treat recurrent glioblastoma multiforme (rGBM).With the approval, the company aims to evaluate the effica
A revocation of the license of Pharma Research Bio’s botulinum toxin (BTX) ReNTox is expected to deal a blow to LG Chem, Pharma Research Bio’s partner company in the Chinese market.On Wednesday, the Ministry of Food and Drug Safety (MFDS) said Pharma Research Bio violated the Pharmaceutical Affairs
Korea Research-based Pharma Industry Association (KRPIA) expressed concerns over the Health Insurance Review Assessment Service’s (HIRA) plan of evaluating a drug’s cost-effectiveness at 80 percent of the lowest drug price in Advanced 7 (A7) countries.The HIRA’s plan was revealed when it replied to
Pharos iBio said its PHI-501, a next-generation anticancer drug for acute myeloid leukemia (AML), has won orphan drug designation from the U.S. Food and Drug Administration (FDA).It was the U.S. regulator’s second orphan drug designation of the Korean company’s product. FDA granted similar status to
Hemophilia patients often call Sanofi’s fitusiran “a dream treatment” because the single subcutaneous injection once a month shows a preventive effect.The investigational drug proved its prophylaxis effect in patients with hemophilia A or B with inhibitors in a recent study, drawing much attention.H
Merck said it has signed a memorandum of understanding (MoU) with GI Innovation, a Korean bioventure company, to further R&D efforts on critical life-saving cancer treatments and drugs for allergy-related conditions.Under the accord, Merck will support GI Innovation with technologies and services, i
GemVax & KAEL said its study results of GV1001 showing an inhibitory effect on prostate cancer cell metastasis was published in the international journal, Cell & Bioscience.The company research team found the possibility that its Alzheimer’s drug candidate GV1001 could be a GnRHR ligand that inhibit
A Pfizer executive said the company is aware of the alleged data fraud suspicion in its clinical trials of the Covid-19 vaccine Cominarty and conducts an internal review.Pfizer Vaccine Vice President Ralf Rene Reinert said at an online meeting that the company confirmed the article published by the
AbbVie is strengthening its position in Korea’s atopic dermatitis treatment market with Rinvoq (ingredient: upadacitinib), a Janus kinase (JAK) inhibitor, armed with new clinical data, the company said Tuesday.The drug recently received approval from the Ministry of Food and Drug Safety for three ad
Dong-A ST’s sales and operating profit increased thanks to the growth of prescription drugs in the third quarter, the company said.As the company improved profitability even before receiving fees for licensing out a Stelara biosimilar to India’s Intas Pharmaceuticals, the company’s earnings are expe
Helixsmith said it has presented the topline data of its phase 1 and 2a clinical trials for Engensis, also known as VM202, for treating Charcot-Marie-Tooth (CMT) disease marked by muscle atrophy and gait disturbance.Professor Choi Byeong-ok Samsung Medical Center, one of the highest authorities on C
Icure Pharmaceutical's Donerion Patch, a donepezil patch product to treat Alzheimer's, is attracting attention after receiving approval from the Ministry of Food and Drug Safety as the world's first such treatment last Friday.According to industry insiders, expectations are high because donepezil ac
An FLT3 inhibitor HM43239, developed by Hanmi Pharmaceutical and licensed out to Aptose Biosciences recently, reported excellent tolerability and anticancer activity in all patients with relapsed or refractory FLT3 mutated and wild-type acute myeloid leukemia (AML), a study showed.At the annual meet
HLB's anticancer drug candidate rivoceranib has won an orphan drug designation from the U.S. Food and Drug Administration for treating liver cancer.The company is conducting global phase 3 clinical trials of rivoceranib and cancer immunotherapy camrelizumab as first-line treatment for liver cancer.H
Prestige Biopharma said that it has received a technology transfer to manufacture the Sputnik Light Covid-19 vaccine from Russia's Human Vaccine and ENSO Healthcare DMCC.Sputnik Light is a single-dose Covid-19 vaccine developed by the Gamaleya National Center of Epidemiology and Microbiology under R
Merck Biopharma Korea and Pfizer Korea said their joint immunotherapy Bavencio (ingredient: avelumab) received approval for treating urothelial carcinoma.Bavencio, the first and only FDA-approved anti-PD-L1 immunotherapy, was first authorized to treat Merkel cell carcinoma in 2019 and received regul
Hanmi Pharmaceutical said it licensed out FLT3 inhibitor (HM43239), an investigational treatment for acute myeloid leukemia (AML), to Aptose Biosciences, a U.S. biotech firm.Aptose is a Nasdaq-listed firm specializing in research and development in hematology, and its headquarters is located in Toro
GC said that the Ministry of Food and Drug Safety has approved using Peramiflu, an intravenous influenza treatment, to treat infants aged six months to two years.The approval came as BioCryst, the raw material manufacturer for Peramiflu, proved its safety and efficacy to the U.S. Food and Drug Admin